The NH-BMT Program diagnoses and treats the following hematological disorders:

• Acute Myelogeneous Leukemia (AML)

• Acute Lymphoblastic Leukemia (ALL)

• Amyloidosis

• Anaplastic Lymphoblastic Lymphoma

• Aplastic Anemia

• Chronic Lymphocytic Leukemia (CLL)

• Chronic Myelogenous Leukemia (CML)

• Hereditary Hemoglobinopathies (Thalassemia, Sickle Cell)

• Hodgkin Disease

• Myelodysplastic Syndrome

• Multiple Myeloma

• Non-Hodgkin Lymphoma (NHL)

• Solid Tumors amenable to transplant therapy

• Waldenstroms Macroglobulinemia